graft versus host disease (GVHD) | Page 5 | Aplastic Anemia & MDS International Foundation Return to top.

graft versus host disease (GVHD)

mRNA COVID-19 Vaccination Sparks Strong Antibody Response in Patients With AML and MDS

The mRNA COVID-19 Vaccines Are Safe and Effective for Most Patients with Cancer
For most patients with cancer, the mRNA COVID-19 vaccines are safe and effective. This article explains the results of the first study that evaluated the safety and effectiveness of the mRNA vaccines in patients with solid cancers, such as lung, breast, or prostate cancer.
November 2021 – Lung Cancer
Laura Morgan

Leslie S. Kean, MD, PhD, on Bone Marrow Transplantation: Using Abatacept to Prevent Graft-vs-Host Disease

Leslie S. Kean, MD, PhD, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center, discusses findings from her analysis of the International Blood and Marrow Transplant Research Database, which led to the recent FDA approval of abatacept for the prevention of acute graft-vs-host disease (GVHD) in adult and pediatric patients. The data suggest improved overall survival with the immunosuppressant abatacept in combination with a calcineurin inhibitor and methotrexate following 7/8 HLA–matched unrelated allogeneic hematopoietic stem cell transplantation (Abstract 3912).

Monitoring Amphiregulin May Be Warranted in Caring for Patients with Acute GVHD

Amphiregulin (AREG) may represent a useful longitudinal monitoring biomarker for patients with life-threatening acute graft-vs-host disease (GVHD), according to a sample of 2 prospective clinical trials that was presented at the 2021 ASH Annual Meeting. Specifically, patients with a high baseline of AREG are at an increased mortality risk and, therefore, should be monitored consistently during serial assessments.

Winter Patient and Family Virtual Conference, November 13, 2021

Event Date: 
Sat, 11/13/2021 - 8:00am (EST)
Conference Event Type: 

Fall Patient and Family Virtual Conference, September 11, 2021

Sessions

Understanding Low Risk MDS 2021 Fall Patient Family Conference
  Suresh Balasubramian, MD, Karmanos Cancer Center

Understanding Aplastic Anemia 2021 Fall Patient Family Conference
  Daria Babushok, MD, PhD, Penn Medicine

Event Date: 
Sat, 09/11/2021 - 8:00am (EDT)
Conference Event Type: 

Summer Patient and Family Virtual Conference, July 17, 2021

Sessions

Managing the Side Effects of Bone Marrow Failure - Summer 2021 Conference
 Eric Padron, MD, Moffitt Cancer Center

Diagnosing Bone Marrow Failure Diseases - Summer 2021 Conference
 Amy Duffield, MD, PhD, Memorial Sloan Kettering

Event Date: 
Sat, 07/17/2021 - 8:00am (EDT)
Conference Event Type: 

Aplastic Anemia, Myelodysplastic Syndromes, and Myeloproliferative Neoplasms: The 8th (Virtual) Patient Conference, June 26, 2021

Sessions

8th Seattle Patient Conference: Ask an Expert
 H. Joachim Deeg, MD

8th Seattle Patient Conference - Living Well with MDS/MPN
 Krisstina Gowin, DO, University of Arizona

Event Date: 
Sat, 06/26/2021 - 8:00am (EDT)
Conference Event Type: 

Spring Patient and Family Virtual Conference, April 10, 2021

Event Date: 
Sat, 04/10/2021 - 8:00am (EDT)
Conference Event Type: 
Share with addtoany.com.